Overview

Update
Total Equity Funding
$57.94M in 2 Rounds from 8 Investors
Most Recent Funding
$30.4M Series B on March 20, 2017
Headquarters:
London, England
Description:
Pulmocide is focused on the development of inhaled medicines for the treatment of viral and fungal infections of the respiratory tract.
Founders:
,
Categories:
Medical Device, Health Care, Health Diagnostics
Website:
http://www.pulmocide.com
Social:

Company Details

Update
Founded:
2013
Contact:
+44 207 594 1210
Employees:
11 - 50 | 3 in Crunchbase

Pulmocide Ltd, a company focused on the discovery and development of a new generation of inhaled medicines for the treatment of serious viral and fungal infections of the respiratory tract.

Funding Rounds (2) - $57.94M

Update
DateAmount / RoundValuationLead InvestorInvestors
Mar, 2017$30.4M / Series B6
Nov, 2013£17M / Series A4

Current Team (3)

Update

Offices/Locations (1)

Update
  • Imperial BioIncubator

    Prince Consort Road

    Level 1 Bessemer Building (RSM)

    London, England SW7 2BP

    United Kingdom

Add Acquisitions

Add Board Members and Advisors

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Images

Add Videos